Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022

SELL
$4.65 - $7.23 $67,890 - $105,558
-14,600 Closed
0 $0
Q2 2021

Jul 14, 2021

SELL
$6.35 - $10.0 $31,102 - $48,980
-4,898 Reduced 25.12%
14,600 $141,000
Q1 2021

Apr 19, 2021

BUY
$7.03 - $16.51 $106,673 - $250,522
15,174 Added 350.93%
19,498 $155,000
Q4 2020

Jan 22, 2021

BUY
$5.76 - $11.95 $24,906 - $51,671
4,324 New
4,324 $29.5 Million

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.